Abstract
Sarcopenia is a complex multifactorial condition that can by treated with multimodal approaches. No pharmacologic agent to prevent or treat sarcopenia has been as efficacious as exercise (mainly resistance training) in combination with nutritional intervention (adequate protein and energy intake). However, performing resistance training sessions and following nutritional advice can be challenging, especially for frail, sarcopenic, elderly patients, and results remain only partial. Therefore, new pharmacologic agents may substantially reduce the functional decline in older people. This article reviews the new pharmacologic agents currently being assessed for treating sarcopenia.
Lingua originale | English |
---|---|
pagine (da-a) | 423-447 |
Numero di pagine | 25 |
Rivista | Clinics in Geriatric Medicine |
Volume | 27 |
DOI | |
Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Aged
- Aging
- Angiotensin-Converting Enzyme Inhibitors
- Drug Therapy
- Frail Elderly
- Hormones
- Humans
- Muscle Weakness
- Sarcopenia